Lv1
40 积分 2021-11-23 加入
A multicenter assessment of recombinant factor VIIa off‐label usage: clinical experiences and associated outcomes
6小时前
待确认
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations
1个月前
已完结
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2个月前
已完结
Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma
4个月前
已关闭
Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma
4个月前
已关闭
Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma
4个月前
已完结
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial
4个月前
已完结
A prospective, multicenter study of bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory iMCD
4个月前
已完结
Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study
4个月前
已完结
Feasibility of plasma proteomics in patients with immune thrombocytopenia
5个月前
已完结
皖公网安备34019202002308
